HHS Secretary Alex Azar has chosen Adam Boehler to help oversee efforts to develop value-based care initiatives at the agency.
The Senate Health, Education, Labor and Pensions Committee held its second hearing on healthcare spending Tuesday, with lawmakers and witnesses trying to drill down on big questions that could lead to concrete health policy.
A federal district judge rejected Planned Parenthood and the ACLU's bid to freeze the Trump administration's new funding criteria for the Title X family planning program, leaving the existing network of grantees in limbo.
The Trump administration's effort to reduce drug prices should not include altering or cutting the 340B program as it won't lead to lower drug costs, hospitals are telling HHS.
UnitedHealth Group saw revenue climb 13.3% in the first quarter of 2018 over the prior-year period. What does Q2 have in store?
HHS Secretary Alex Azar in a meeting with several key House GOP lawmakers suggested standardizing the discount for 340B drugs at 20% of list price, far below the current 40% to 60% discount.
An expansive HSA-focused package of bills passed the House Ways and Means Committee largely along party lines following a two-day hearing.
The House HHS appropriations committee passed amendments to its $177 billion health funding bill to soften and chip away at the Trump administration's rescinded family separation policy and the continued fallout.
Judge Brett Kavanaugh, nominated to be the newest justice on the U.S. Supreme Court, has written opinions and law review articles that offer hope and caution for the future of the Affordable Care Act and Medicaid expansion.
The CMS is chopping funding available for federal exchange navigators to $10 million, down from $36 million last year. Groups winning contracts will be expected to promote not just qualified health plans but also association and short-term plans as well.
A bundle of GOP-led bills under consideration would restrict the 340B drug discount program more than any other proposal so far. Critics claim the program has been exploited by bad actors.
Brett Kavanaugh, a federal appellate judge, comes with a long paper trail on healthcare issues including the Affordable Care Act. His conservative credentials nearly guarantee strong opposition from Senate Democrats and liberal advocates.